Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can heart surgery rehab move from hospital to home?

NCT ID NCT07811102

Symptom relief Sponsor: Cheng-Hsin General Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 09, 2026 · Last updated Sep 10, 2026 · Updated 1 time

Summary

Researchers are testing whether a hybrid cardiac rehabilitation programme can help adults recover after heart surgery. Participants start with two weeks of supervised exercise at the hospital, then continue training at home for six weeks using heart-rate monitors, a cloud care platform, weekly phone calls and text messages. The trial compares this approach with standard centre-based rehabilitation, which involves eight weeks of supervised sessions at the hospital. The main measure is change in peak oxygen uptake, a marker of fitness, after eight weeks.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
hybrid cardiac rehabilitation, a programme that starts supervised exercise in hospital and continues at home with heart-rate monitoring and remote support
What this could lead to
If it works, patients recovering from heart surgery could complete rehabilitation at home with remote monitoring instead of attending hospital for every session.
What could go wrong
This is a small pilot study of 30 people, so it can only estimate whether the approach is worth testing in a larger trial. Home-based exercise may not suit everyone, and remote supervision may not match in-person care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

30 people

The number who actually took part.

Started

Jun 2023

Finished

Mar 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

20 to 75 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria * Aged 20 to 75 years. * Admitted to the department of cardiovascular surgery and undergoing cardiac surgery during the index admission. * Meeting the indications for cardiac rehabilitation. * Classified as low risk (Class B) for exercise training according to the 2013 American Heart Association exercise standards, that is, clinically stable coronary artery disease, valvular heart disease, congenital heart disease, cardiomyopathy, or an abnormal exercise test not reaching high-risk criteria. * Able to self-monitor exercise intensity. Exclusion Criteria * An irreversible condition causing exercise intolerance or limiting exercise capacity. * Persistent atrial fibrillation or non-sustained ventricular tachycardia within the preceding six months, an implanted defibrillator, or any other rhythm that could compromise the reliability of home heart-rate recording. * Hypertrophic cardiomyopathy or recent myocarditis. * New York Heart Association class III or IV; angina or ischaemic electrocardiographic change during moderate-intensity exercise; a fall in systolic blood pressure during exercise; non-sustained ventricular tachycardia; previous cardiac arrest; or any condition judged by the physician to be potentially life-threatening. * During the study, reported adverse symptoms or escalation of exercise-training risk to Class C or D, including suspected angina, abnormal dyspnoea, vomiting or syncope, or an emergency department visit or readmission. * Unable to operate the communication and exercise applications independently. * Declined to take part in testing.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cardiac rehabilitation are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cardiomyopathy congenital heart disease coronary artery disorder heart valve disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cardiac rehabilitation Cardiac surgical procedures Coronary artery disease Heart valve diseases Telerehabilitation

Contacts and locations

Locations

  • Cheng Hsin General Hospital

    Taipei, 11220, Taiwan

More trials for these conditions

Other studies related to the condition(s) this trial covers.